Associations between blood cell-based inflammatory indices and their changes and mortality in patients undergoing

Weiya Li1,2,3, Hongde Li1,2,3, Shiqin Peng1,2,3

  • 1Department of Cardiology, West China Hospital, Sichuan University, Chengdu, People's Republic of China.

Insights

Post-transcatheter aortic valve replacement (TAVR) inflammatory markers, including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and neutrophil percentage-to-albumin ratio (NPAR), predict mortality better than pre-TAVR values. NPAR is the most potent predictor for risk stratification.

Area of Science:

  • Cardiovascular Medicine
  • Inflammation and Immunology
  • Medical Diagnostics

Background:

  • Chronic inflammation drives cardiovascular diseases like valvular calcification.
  • Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and neutrophil percentage-to-albumin ratio (NPAR) are key systemic inflammation markers.
  • Limited research exists on dynamic changes of these markers predicting outcomes post-transcatheter aortic valve replacement (TAVR).

Purpose of the Study:

  • To evaluate the predictive value of pre- and post-TAVR inflammatory markers (NLR, PLR, NPAR) for all-cause mortality.
  • To assess the impact of dynamic changes in these markers on mortality risk.
  • To compare the predictive power of pre-TAVR versus post-TAVR inflammatory marker levels.

Main Methods:

  • Retrospective single-center cohort (n=1629) and prospective multicenter cohort (n=443) studies.
  • Stratification into tertiles based on pre- and post-TAVR NLR, PLR, and NPAR.
  • Multivariate Cox regression, restricted cubic spline (RCS), and time-dependent ROC curve analyses were used.

Main Results:

  • Higher tertiles of pre- and post-TAVR NLR, PLR, and NPAR were associated with increased all-cause mortality.
  • Post-TAVR inflammatory markers showed greater predictive value for mortality than pre-TAVR values.
  • An increase in post-TAVR markers from baseline significantly elevated mortality risk; findings were validated in the prospective cohort.

Conclusions:

  • Post-TAVR NLR, PLR, and NPAR are superior predictors of mortality compared to pre-TAVR values, with NPAR being the most significant.
  • These blood cell-based inflammatory markers enable precise risk stratification for TAVR patients.
  • Further interventional studies targeting these markers, particularly NPAR, are recommended.
Abstract